UBS upgraded AstraZeneca (AZN) to Buy from Neutral with a price target of 14,200 GBp, up from 11,500 GBp. The firm cites the company’s ...

In a report released today, Matthew Weston from UBS upgraded AstraZeneca (AZN – Research Report) to a Buy, with a price target of £142.00. The ...

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...

We recently published a list of 10 Safest Dividend Stocks in the UK. In this article, we are going to take a look at where ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday.

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of ...

Univar Solutions LLC ("Univar Solutions" or "the Company") announced it has acquired UK-based Brad-Chem Holdings ("Brad-Chem") and its affiliated entities, which includes the acquisition of Brad-Kem, ...

QKS Group has named Cleafy as a technology leader in their SPARK Matrixtm Enterprise Fraud Management 2024. The QKS Group SPARK Matrixtm evaluates ...

British pharmaceutical giant AstraZeneca reported on Thursday a pre-tax profit of $1.666 billion for the fourth quarter, an 86% increase from $897 million in the same quarter the previous year. This ...

AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's former senior executive Leon Wang and has provided information as needed, its ...

European markets are set for a positive open Thursday, with investors awaiting more earnings and the latest monetary policy ...